Foundations Investment Advisors LLC Makes New Investment in iShares U.S. Pharmaceuticals ETF $IHE

Foundations Investment Advisors LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 642,617 shares of the company’s stock, valued at approximately $54,513,000. Foundations Investment Advisors LLC owned approximately 5.74% of iShares U.S. Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently bought and sold shares of the stock. National Bank of Canada FI grew its position in shares of iShares U.S. Pharmaceuticals ETF by 42.7% in the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after purchasing an additional 175 shares during the period. NBC Securities Inc. grew its position in shares of iShares U.S. Pharmaceuticals ETF by 46.5% in the fourth quarter. NBC Securities Inc. now owns 630 shares of the company’s stock valued at $53,000 after purchasing an additional 200 shares during the period. U.S. Capital Wealth Advisors LLC grew its position in shares of iShares U.S. Pharmaceuticals ETF by 2.8% in the fourth quarter. U.S. Capital Wealth Advisors LLC now owns 7,608 shares of the company’s stock valued at $645,000 after purchasing an additional 204 shares during the period. Wealthcare Advisory Partners LLC grew its position in shares of iShares U.S. Pharmaceuticals ETF by 4.4% in the third quarter. Wealthcare Advisory Partners LLC now owns 5,115 shares of the company’s stock valued at $371,000 after purchasing an additional 217 shares during the period. Finally, TD Waterhouse Canada Inc. grew its position in shares of iShares U.S. Pharmaceuticals ETF by 34.9% in the fourth quarter. TD Waterhouse Canada Inc. now owns 870 shares of the company’s stock valued at $74,000 after purchasing an additional 225 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Up 0.7%

Shares of NYSEARCA:IHE opened at $91.87 on Thursday. The company has a market cap of $992.20 million, a P/E ratio of 17.75 and a beta of 0.49. iShares U.S. Pharmaceuticals ETF has a 52 week low of $63.76 and a 52 week high of $92.48. The business has a fifty day simple moving average of $87.36 and a 200-day simple moving average of $86.55.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.